Accelerate to discover

Homepage>Discover>Assessment of CAR T Cell killing capacity against solid tumors-Thursday, October 20, 2016, 5 pm CEST

Nov 8, 2019

Hyperpolarized (HP)-13C MR is proven as a viable tool for imaging of neurological disorders often associated with...

Webinar recording: Use of ultra-high field MRI for in and ex vivo neuroimaging

Nov 6, 2019

The relatively low T1 contrast, long T1 values at higher fields lead to the necessity to adapt sequences commonly used...

Imaging Flow Cytometry webinar: aging cells, giant viruses using AMNIS platform

Nov 6, 2019

In this webinar we will describe three recent applications for imaging flow cytometry (IFC), a technology that combines...

Join the webcast: Addressing cancer gene therapy efficacy with IncuCyte Live–Cell Imaging

Oct 29, 2019

During this webinar, Dr Pierre Cordelier will discuss the use of IncuCyte Live-Cell Imaging and Analysis, to track gene...

Nov 11, 2019

Acquisition and analysis of reproducible high-complexity cytometry data using the Cytek Aurora

Oct 8, 2019

We invite you to join us on Friday, October 11 at 8:00 PM CET to hear more about Cytek collaborative...

Webinar recording - Highly sensitive structural variant detection for medical genetics

Oct 4, 2019

Follow the webinar outlining how a team at Radboud University Medical Center is assessing ultra-long read optical...

What if NMR was easy? Aspects & applications of the Fourier 80 FT-NMR benchtop spectrometer

Oct 1, 2019

What if there was a NMR instrument everybody could operate, that is as easy to use as infrared spectroscopy and as easy...

Nov 11, 2019

Cytek webinar - the new age of spectral flow cytometry

Sep 9, 2019

The Cytek Aurora flow cytometer has made more than twenty-four color flow cytometry panels possible with only three...

Show all topics (10)

Assessment of CAR T Cell killing capacity against solid tumors-Thursday, October 20, 2016, 5 pm CEST

Oct 13, 2016

Nabil Ahmed, M.D., M.P.H. Associate Professor of Pediatrics, Baylor College of Medicine (USA).

Robust CAR design and sensitive yet realistic functional testing will be required in order to improve the efficacy of CAR T cell therapies targeting solid tumors. We have used the xCELLigence Real-Time Cell Analyzer as a high-throughput platform to test multiple CAR components including extracellular domains (including bi-specifics), signaling endo-domains, as well as next-generation CAR T cell products that are inherently resistant to checkpoint blockade. This platform has proven very sensitive to subtle yet longitudinally meaningful differences in CAR design, and has made it possible to evaluate T cell products in a "stress test" that is more representative of early phase trial requirements.

Register now

Webinar

Related technologies: Real-time, label free cell analysis

Get more info